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A Skin-Like Cytochrome P450 Cocktail Activates
Prohaptens to Contact Allergenic Metabolites
Moa Andresen Bergstro¨m1, Hagen Ott2, Anna Carlsson1, Mark Neis2, Gabriele Zwadlo-Klarwasser2,3,
Charlotte A.M. Jonsson1, Hans F. Merk2, Ann-Therese Karlberg1 and Jens M. Baron2
Allergic contact dermatitis is a complex syndrome representing immunological responses to cutaneous
exposure to protein-reactive chemicals. Although many contact sensitizers directly can elicit this disorder,
others (prohaptens) require activation. Knowledge regarding the activating mechanisms remains limited, but
one possibility is metabolic activation by cytochrome P450 (CYP) enzymes in the skin. We have, after
quantitative reverse transcriptase-PCR studies of the CYP content in 18 human skin samples, developed an
enriched skin-like recombinant human (rh) CYP cocktail using CYP1A1, 1B1, 2B6, 2E1, and 3A5. To validate the
rhCYP cocktail, a prohaptenic conjugated diene ((5R)-5-isopropenyl-2-methyl-1-methylene-2-cyclohexene) was
investigated using: the skin-like rhCYP cocktail, a liver-like rhCYP cocktail, single rhCYP enzymes, liver
microsomes, keratinocytes, and a dendritic cell (DC) assay. The diene was activated to sensitizing epoxides in all
non-cell-based incubations including the skin-like rhCYP cocktail. An exocyclic epoxide metabolite ((7R)-7-
isopropenyl-4-methyl-1-oxaspiro[2.5]oct-4-ene) was found to be mainly responsible for the allergenic activity of
the diene. This epoxide also induced pronounced DC activation indicated by upregulation of IL-8. The skin-like
rhCYP cocktail provides a simplified alternative to using skin tissue preparations in mechanistic studies of CYP-
mediated skin metabolism of prohaptens and offers the future possibility of designing in vitro predictive assays
for assessment of allergenic activity of prohaptens.
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INTRODUCTION
Ten to fifteen percent of Europeans are estimated to be
sensitized to one or more chemicals (Nielsen et al., 2001).
Hence, it is important to identify and evaluate the sensitizing
potency of chemical allergens to provide accurate risk
assessments regarding their safe use and to prevent potent
sensitizers from entering the market. The murine local lymph
node assay (LLNA) (Kimber et al., 1995) has become the most
widely used assay for identification and potency assessment
of contact allergens. However, animal-based assays are of
major concern to regulatory authorities, which has led to an
increasing interest in alternative assays based on in vitro
techniques (Gerberick et al., 2004; Vandebriel et al., 2005),
such as human dendritic cell (DC) assays (Aeby et al., 2004;
Ryan et al., 2005; Toebak et al., 2006) and in silico methods
(Fedorowicz et al., 2005).
Most contact allergens contain a chemically reactive
moiety in their molecular structure and are considered to
react with nucleophilic amino acids in proteins, thus forming
antigens. However, some contact allergens are sensitizing but
have no or low chemical reactivity. These compounds are
referred to as prohaptens and are believed to be activated into
reactive products (haptens) able to induce contact allergy
(Smith and Hotchkiss, 2001). This activation process may
either be non-enzymatic or enzymatic. Generally, bioactiva-
tion of xenobiotics includes oxidative processes and it has
been suggested that most oxidative bioactivation reactions
may be attributed to cytochrome P450 (CYP) (Guengerich and
Shimada, 1991; Guengerich, 2001). CYP is believed to play a
major role in activation of procarcinogenic compounds, such
as polyaromatic hydrocarbons, and could play an equally
large role in the activation of prohaptens in contact allergy.
However, the possibility of prohaptens being targets for CYP-
mediated activation has only been briefly studied (Smith et al.,
2000; Sieben et al., 2001; Cheung et al., 2003).
Prohaptens can be identified as sensitizers in the LLNA,
but their potency determination is dependent on the murine
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metabolic system to mimic that of the human. Alternative
methods that do not take skin metabolism into account will
not detect prohaptens as sensitizers. Investigations of the
mechanisms by which prohaptens become activated are
required before prohapten-detecting assays can be devel-
oped. Liver microsomes, hepatocytes, or liver tissue samples
are commonly used in studies of xenobiotic metabolism
(Evans et al., 2004). However, the metabolic activity of the
liver differs both qualitatively and quantitatively from the
skin, as different CYP enzymes are expressed in the two
tissues (Baron et al., 2001; Merk et al., 2004; Swanson,
2004). Studies of cutaneous metabolism using skin cells or
fresh human skin often require preparation of microsomal
fractions, metabolites formed in relatively high amounts or
use of radioactively labeled substrates (Duell et al., 1992;
Marikar et al., 1998), as the total amount of metabolizing
enzymes in the skin is considerably lower than that of the
liver (Smith and Hotchkiss, 2001).
In this study, the alternative approach of developing an
enriched skin-like recombinant human (rh) CYP cocktail
using the major CYP enzymes found in the skin is described.
A similar methodology has previously been used by Ha¨rtter
et al. (2002) in the development of a liver-like rhCYP cocktail
(Table 1). This liver-like rhCYP cocktail is based on data of
the amounts of individual CYP enzymes and total CYP
content in human liver microsomes (Shimada et al., 1994;
Friedberg et al., 1999; Schmitt et al., 2006). During studies of
the metabolic activation of our model prohapten, the
conjugated diene (5R)-5-isopropenyl-2-methyl-1-methylene-
2-cyclohexene, we realized that an enriched skin-like rhCYP
cocktail would be of great value for the identification of
reactive metabolites in a system that is more similar to the
human skin than conventional CYP-containing preparations.
We have previously shown that this diene is a prohapten
and that its allergenic activity is exerted by two sensitizing
epoxides: (4S)-1,2-epoxy-4-isopropenyl-1-methyl-6-methyl-
ene-cyclohexane (endocyclic epoxide) and (7R)-7-isoprop-
enyl-4-methyl-1-oxa-spiro[2.5]oct-4-ene (exocyclic epoxide)
(Figure 1) (Nilsson et al., 2005). These epoxides were shown
to be formed by metabolic conversion of the diene in liver
microsomal incubations (Nilsson et al., 2005).
Thus, the aims of this study were to develop a skin-like
rhCYP cocktail and to evaluate it by studying the metabolic
activation of the conjugated diene as a model prohapten. To
allow comparisons with other metabolic systems often used,
incubations with the following additional metabolic prepara-
tions were carried out: the liver-like rhCYP cocktail, the
individual major rhCYP enzymes present in the skin and liver,
human and murine liver microsomes, and normal human
epidermal keratinocytes (NHEKs). We also studied the ability
of the diene and its metabolites to affect the IL-8 mRNA
expression in immature human DCs. Human DCs have
previously been employed to assess the sensitizing potential
of low molecular weight compounds, as exposure to contact
sensitizers, but not to irritants alters their cell surface marker
profiles and cytokine gene expression patterns. In particular,
marked IL-8 upregulation has been shown to occur during
DC exposure to contact allergens (Aiba et al., 2003; Toebak
et al., 2006).
RESULTS
Development of the enriched skin-like rhCYP cocktail
Global analysis of CYP enzymes expressed in human skin
tissue was performed using oligonucleotide microarray
analysis. Expression of CYP1A1, 1B1, 2B6, 2E1, and 3A5
was detected as ‘‘present’’ or ‘‘marginal’’ by the array
analysis software and expression of CYP2C9 and 3A4 as
‘‘marginal’’ or ‘‘absent’’ (Table S1). The expression of 24
other well-characterized CYP enzymes was not detected in
the skin tissue but was partly present in the liver tissue. The
CYP enzymes that were detected as ‘‘present’’ or ‘‘marginal’’
by array analysis were further analyzed by quantitative
reverse transcriptase-PCR. The PCR analysis showed a
significant mRNA expression for CYP1A1, 1B1, 2E1, and
3A5 and a weak expression of CYP 2B6. Expression of
CYP2D6, 2C9, and 3A4 was significantly lower than other
Table 1. rhCYP content of skin-like and liver-like
rhCYP cocktails
CYP content (pmol)
Skin-like rhCYP cocktail
CYP1A1 3.6
CYP1B1 2.0
CYP2B6 0.035
CYP2E1 11
CYP3A5 5.6
Total CYP content 22
Liver-like rhCYP cocktail1
CYP1A2 20
CYP2C9 17
CYP2C19 8.0
CYP2D6 3.0
CYP2E1 11
CYP3A4 45
Total CYP content 104
rhCYP, recombinant human cytochrome P450.
1According to Ha¨rtter et al. (2002).
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Figure 1. CYP-mediated metabolism of the diene to the endocyclic and
exocyclic epoxide followed by hydrolysis of the exocyclic epoxide to a diol.
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CYP enzymes and expression of 2C19 was hardly detectable.
Subsequently, the skin-like rhCYP cocktail was prepared
using the major CYP enzymes found in the skin, that is
CYP1A1, 1B1, 2B6, 2E1, and 3A5, which also correlates with
the expression data found for NHEKs and dermal fibroblasts
(Baron et al., 2001; Gonzalez et al., 2001; Janmohamed
et al., 2001; Saeki et al., 2002). As the total CYP content in
the skin samples was considered insufficient for the in vitro
experiments, it was correlated to the liver-like system.
The same amount of CYP2E1 as present in the liver-like
system developed by Ha¨rtter et al. (2002) was used and the
amounts of the remaining skin CYP enzymes (i.e. CYP1A1,
1B1, 2B6, and 3A5) were increased by using the same factor
as used for CYP2E1. As a result, the CYP content was
enriched approximately 1,000-fold, however the ratios
between the individual CYP enzymes are still the same
in the cocktail as in the skin. The rhCYP contents of the
skin-like and liver-like enzyme cocktails are shown in Table 1
and these cocktails were used in subsequent incubation
experiments.
Stability of epoxides
Before the microsomal incubations of the diene, the stability
of the epoxides in phosphate and N-2-hydroxyethylpiper-
azine-N0-2-ethanesulfonic acid (HEPES) buffer (pH 7.4) was
studied at 371C for 15 minutes. The endocyclic epoxide was
shown to be moderately stable and recoveries of 75%,
compared to immediately extracted samples, were obtained
in both buffers. In contrast, the exocyclic epoxide underwent
rapid degradation by water hydrolysis and only 4 and 11%
remained after incubation in phosphate and HEPES buffer,
respectively. The major hydrolysis products formed from the
exocyclic epoxide were two diastereomeric diols (ratio 6:1)
(Figure 1) afforded in 70% total yield as determined by liquid
chromatography/mass spectrometry (LC/MS).
Liver microsomal incubations
As expected from the stability experiments, only trace
amounts of the exocyclic epoxide could be detected in
incubations of the diene with mouse or human liver
microsomes. The endocyclic epoxide was detected in most
incubations, but the amounts were relatively low in relation
to the detected amounts of the major diol formed from the
exocyclic epoxide (Figure 2a and b).
Keratinocyte incubations
No (5R)-1-hydroxymethyl-5-isopropenyl-2-methylcyclohex-
2-ene-1-ol (diol of the exocyclic epoxide) could be detected
in the supernatants from the NHEK incubations (data not
shown). Analysis of the exocyclic and endocyclic epoxide
content was not carried out, as these metabolites were
considered to be unstable at the incubation conditions (8 or
24 hours at 371C).
Incubation with rhCYP cocktails
The endocyclic epoxide and the diol of the exocyclic epoxide
were detected in all incubations (Figure 3a and b) showing
that the metabolic activation of the diene is CYP-mediated.
Only traces of the exocyclic epoxide could be detected.
Lower amounts of the metabolites were found in the skin-like
as compared to the liver-like cocktail incubations. This is
likely due to the total CYP content in the skin-like cocktail
(22 pmol) being approximately five times lower compared to
that of the liver-like cocktail (104 pmol) (Table 1).
Incubation with single rhCYP enzymes
Single rhCYP enzyme incubations were carried out to
investigate, which specific enzymes that are responsible for
the metabolic activation of the diene in the rhCYP cocktails
(Figure 4a and b). The diol of the exocyclic epoxide was
formed in all incubations, showing that the diene is able to fit
into the active site and be catalyzed by many different classes
of CYP enzymes. However, CYP2C19, present in the liver
and CYP2B6, present in the skin generated particularly high
levels of the diol. The endocyclic epoxide was detected in
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Figure 2. Metabolic activation of the diene in liver microsomal incubations.
Detected amounts of the endocyclic epoxide (’) and the diol of the exocyclic
epoxide (&) in incubations with the (a) mouse and (b) human liver
microsomes. The microsomal incubations were performed using human or
mouse liver microsomes (0.5 mg of protein), substrate (200 mM), potassium
phosphate buffer (100 mM, pH 7.4), and a NADPH-regenerating system in a
total volume of 500 ml. The incubations were terminated after 15, 30, or
60 minutes and analyzed using GC/MS and LC/MS. The detections limits for
the endocyclic epoxide and the diol of the exocyclic epoxide are 5 and
25 pmol (total amount in incubation mixture), respectively. The figure shows
the total amounts formed of the metabolites in the incubation mixtures,
presented as means of two individual incubations. ND¼ not detected.
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incubations with CYP1A2, 3A4, 2C19, 2E1, and 1A1, but the
amounts were less than half of the amounts detected of the
major diol of the exocyclic epoxide.
Incubation of cinnamic alcohol with the skin-like CYP cocktail
The metabolic activation of the prohapten cinnamic alcohol
(CAlc) to cinnamic aldehyde (CAld) and cinnamic acid was
studied in order to further validate the skin-like rhCYP
cocktail. CAld (315 and 505 pmol, means of two individual
incubations) was detected in incubations performed for 15
and 30 minutes, respectively. Cinnamic acid, which can be
formed by further oxidation of CAld, was not detected.
In vivo sensitizing capacity of the diol
The major diol of the exocyclic epoxide was tested for
sensitizing capacity in the LLNA. The diol was shown to be
non-sensitizing/weak sensitizer, as none of the tested con-
centrations (1–22% (w/v), 0.055–1.2 M) provoked a stimula-
tion index of three (Table S2, Figure S1).
In vitro activation of human DCs
The diene, the epoxides, and the diol were incubated with
monocyte-derived immature human DCs and the IL-8 mRNA
expression was measured as an indicator of allergen-induced
DC activation (Figure 5). 2,4,6-Trinitrobenzene sulfonic acid
was used as a positive control, whereas DMSO, the irritant
SDS, as well as medium-only incubations were used as
negative controls. Incubation with the strongly allergenic
exocyclic epoxide (Table 2) resulted in an approximately 30
times higher upregulation of IL-8 mRNA expression com-
pared to medium-treated controls, whereas incubation with
the diene afforded a 3.6-fold increase. Both the endocyclic
epoxide and the diol of the exocyclic epoxide failed to
induce any major changes in IL-8 mRNA expression
compared to negative controls.
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Figure 3. Metabolic activation of the diene in rhCYP cocktail incubations.
Detected amounts of the endocyclic epoxide (’) and the diol of the exocyclic
epoxide (&) in incubations with the (a) liver and (b) skin system. The
incubations were performed using the liver-like and skin-like cocktail
(prepared by mixing recombinantly expressed CYP enzymes according to
Table 1), substrate (200 mM), HEPES buffer (50 mM, pH 7.4), MgCl2 (30 mM),
and NADPH (1 mM) in a total volume of 500ml. The incubations were
terminated after 15, 30, or 60 minutes and analyzed using GC/MS and LC/MS.
The detections limits for the endocyclic epoxide and the diol of the exocyclic
epoxide are 5 and 25 pmol (total amount in incubation mixture), respectively.
The figure shows the total amounts formed of the metabolites in the
incubation mixtures, presented as means of two individual incubations.
TD¼ traces detected.
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Figure 4. Metabolic activation of the diene in incubations with rhCYP
enzymes. Detected amounts of the endocyclic epoxide (’) and the diol of the
exocyclic epoxide (&) in incubations with single recombinant CYP enzymes
present in the (a) liver- and (b) skin-like rhCYP cocktails. The incubations
were performed using recombinant human CYPs (20 pmol; CYP1A1, 3A5,
1B1, 2B6, 2E1, 1A2, 3A4, 2C9, 2C19, or 2D6), substrate (200 mM), HEPES
buffer (50 mM, pH 7.4), MgCl2 (30 mM), and NADPH (1 mM) in a total volume
of 500 ml. The incubations were terminated after 30 minutes and analyzed
using GC/MS and LC/MS. The detections limits for the endocyclic epoxide
and the diol of the exocyclic epoxide are 5 and 25 pmol (total amount in
incubation mixture), respectively. The figure shows the total amounts formed
of the metabolites in the incubation mixtures, presented as means of two
individual incubations. ND¼not detected.
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DISCUSSION
The hypothesis that prohaptens can be activated by
cutaneous metabolism has existed for more than 20 years,
yet the knowledge regarding the mechanisms of the activa-
tion is still in its infancy. However, the consideration of
metabolic activation has become important when developing
alternative non-animal-based assays for prediction of contact
allergenic activity. In this study, we are presenting a new
concept for studies of activation of prohaptens and CYP-
mediated skin metabolism. We have developed an enriched
skin-like rhCYP cocktail, which can be used for identification
of prohapten metabolites. This experimental design can also
be expected to be of future interest when developing in vitro
predictive assays, which also consider prohaptens. The
cocktail consists of the most common CYP enzymes found
in the skin, but has a higher total CYP content in order to
increase the metabolic activity in in vitro experiments and to
facilitate metabolite identification. Thus, the purpose of this
CYP cocktail is not to exactly mimic the levels of metabolic
activities of the skin, but to provide a tool for studies of
cutaneous CYP-mediated metabolism. The CYP cocktail
presented in this study should be viewed as a prototype and
should also, as the knowledge regarding cutaneous CYP
enzymes expands, be modified. Future modifications of the
cocktail formula could also consist of addition of non-CYP-
based enzymes such as reductive, hydrolytic and/or phase II
metabolic enzymes.
Currently, the skin-like rhCYP cocktail composition is
based on cutaneous CYP amounts found on mRNA level,
which may not fully represent the amounts on protein level.
Quantification of cutaneous CYP enzymes on protein level is
difficult, as the amounts are low and current analytical
techniques not sufficiently sensitive. All recently published
studies analyzing the CYP content in skin cells either used
PCR or in situ hybridization techniques (Baron et al., 2001;
Gonzalez et al., 2001; Janmohamed et al., 2001; Saeki et al.,
2002; Du et al., 2006). Studies of NHEKs (Baron et al., 2001)
have revealed significant protein expression of CYP1A1, 2B6,
2E1, and 3A using immunoblotting. In addition, functional
activity of CYP enzymes was demonstrated by 7-ethoxy-
resorufin-O-deethylase, 7-pentoxyresorufin-O-deethylase,
para-nitrophenol hydroxylase, and erythromycin-N-demethyl-
ase assays (Baron et al., 2001). However, in order to enhance
the specific protein content, these experiments had to be
performed using microsomal preparations from cultured
keratinocytes. Furthermore, such functional assays are often
not specific enough to detect the activity of individual CYP
isozymes and specific monoclonal antibodies are not
available for all skin CYP enzymes. However, with the
discovery of new antibodies as well as novel CYP enzymes,
the skin-like rhCYP cocktail may in the future continually be
improved in order to better resemble the physiological
conditions of human skin.
In this study, in conjunction with the development of the
skin-like rhCYP cocktail, the metabolic activation of a
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Figure 5. In vitro sensitizing capacity of the diene, the epoxides and the diol
in a DC assay. Immature human DCs were incubated with 1: diene (100 mM),
2: exocyclic epoxide (200 mM), 3: endocyclic epoxide (200 mM), and
4: major diol of the exocyclic epoxide (200 mM). 5: 2,4,6-Trinitrobenzene
sulfonic acid (200 mg/ml) was used as a positive control and 6: DMSO (0.1%)
as well as 7: SDS (5mg/ml) as negative controls. The cells were harvested after
incubation for 30 hours and the mRNA was isolated and analyzed by
quantitative reverse transcriptase-PCR. The measured stimulation of IL-8 was
normalized relative to medium-treated controls. The data shown are medians
of four experiments and the results are expressed as x-fold upregulation
compared to medium-treated controls.
Table 2. Chemical reactivity toward a nucleophilic
peptide and sensitizing potency of the diene, the
exocyclic epoxide, the endocyclic epoxide, and the
diol of the exocyclic epoxide in the LLNA and
DC assay
Compound
Chemical
reactivity1
(+/)2
EC3 in the
LLNA3
(%, w/v)
Classification4
based on
LLNA data
Activity in
DC assay3
(+/)5
Diene 6 7.46 Moderate +
Exocyclic
epoxide
+6 0.406 Strong ++
Endocyclic
epoxide
+6 106 Moderate 
Diol of the
exocyclic
epoxide
7 422 Weak/non-
sensitizer

DC, dendritic cell; LLNA, local lymph node assay.
1The chemical reactivity toward the nucleophilic peptide Pro-His-Cys-
Lys-Arg-Met in DMSO/phosphate buffer (pH 7.4) was studied. The experi-
ments were performed as described previously (Nilsson et al., 2005).
2A plus sign (+) denotes a formation of one or more hapten-peptide
adduct(s) within 24 h. A minus sign (–) signifies that no hapten-peptide
adducts could be detected.
3The experiments were performed as described in Materials and Methods.
4Classification performed according to ECETOC recommendations
(ECETOC, 2003).
5A double-plus sign (++) denotes a strong upregulation of IL-8 compared
to negative controls. A plus sign (+) denotes a weak upregulation of IL-8
compared to negative controls. A minus sign () signifies that no
significant upregulation could be detected.
6Previously published data (Nilsson et al., 2005).
7Data not shown.
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prohaptenic conjugated diene was investigated. These
investigations are part of our ongoing studies of alkene
prohaptens in contact allergy (Nilsson et al., 2005; Bergstro¨m
et al., 2006). To validate the skin-like rhCYP cocktail for
metabolism studies of potential prohaptens in contact allergy,
this model compound was chosen, as it is one of few
proposed prohaptens in contact allergy, which have been
thoroughly investigated mechanistically (Nilsson et al., 2005;
Bergstro¨m et al., 2006). We have, for the first time, shown
that the activation of a conjugated diene to a hapten involves
CYP-mediated metabolism. Several prohaptens in contact
allergy have been proposed to act through CYP-mediated
conversion to reactive species, but this has, to our knowl-
edge, previously never been shown by identification of
reactive metabolites in rhCYP-containing incubations. Our
studies show that all CYP-containing non-cell-based incuba-
tions were able to metabolically convert the diene to an
epoxide-originating diol. No metabolites were detected in the
NHEK incubations, which exemplifies the difficulties of using
skin cells for studies of cutaneous metabolism. The fact that
the known prohapten CAlc also was metabolically activated
to CAld by the skin-like rhCYP cocktail further demonstrates
its wide applicability. CAlc is considered to be mainly
activated by alcohol dehydrogenase but has also been
proposed to be activated by cutaneous CYP enzymes, such
as CYP2E1 (Smith et al., 2000; Cheung et al., 2003).
Based on the results of this study, the exocyclic epoxide is
likely to be mainly responsible for the allergenic activity of
the diene, as this metabolite was formed in higher amounts
than the endocyclic epoxide in the metabolism experiments.
However, it is difficult to estimate the actual amounts of the
epoxides in the skin after exposure to the diene, as they are
inherently susceptible to hydrolytic degradation. The micro-
somal formation of the exocyclic epoxide was monitored
as the formation of its corresponding diol, which was shown
to be inactive in both LLNA and DC experiments. CYP2B6,
an enzyme in the skin-like rhCYP cocktail, was shown to
generate an especially high level of the diol of the exocyclic
epoxide, suggesting its importance for the activation of the
diene in skin tissue. However, this enzyme is only found in
small amounts in the skin relative to the other skin CYPs such
as CYP2E1, and is therefore present at o1% in the skin-like
rhCYP cocktail.
Contact sensitizers have previously been shown to
upregulate the IL-8 mRNA expression in DCs (Aeby et al.,
2004). When added to DCs, the exocyclic epoxide enhanced
the IL-8 mRNA expression, whereas the diene showed only
marginal effects in this regard, corroborating the LLNA data
(Table 2). The limited upregulatory effect of the diene may be
due to a low degree of metabolism mediated by the specific
CYP enzyme panel of mononuclear cells (Baron et al., 1998).
The lack of activity of the endocyclic epoxide may be
explained by its weak allergenicity. This DC assay, as well as
other proposed cell-based predictive assays, suffers from a
limited success in detection of moderate to weak sensitizers
as well as prohaptens (Rougier et al., 2000).
In summary, we have developed a skin-like rhCYP
cocktail, which provides a simplified alternative to using
skin tissue preparations in studies of CYP-mediated skin
metabolism, and offers the future possibility of designing in
vitro predictive assays for assessment of allergenic activity of
prohaptens. We have also, for the first time, shown that the
activation of a conjugated diene to become a hapten involves
CYP-mediated metabolism. Continuing mechanistic studies
and identification of new classes of prohaptens are essential
and will prevent potent contact allergens from entering the
market.
MATERIALS AND METHODS
The studies were approved by the ethical committee of the
University Hospital, RWTH, Aachen. Participants gave their written
informed consent, and the study was conducted according to the
Declaration of Helsinki Principles. All animal procedures were
approved by the ethics committee in Go¨teborg.
Chemicals and analytical methods
The diene, the exocyclic epoxide and the endocyclic epoxide were
synthesized as described previously (Nilsson et al., 2005). The diol
of the exocyclic epoxide was synthesized by acid-mediated
hydrolysis of the exocyclic epoxide in aqueous sulfuric acid (2 M)/
acetonitrile (1:2) followed by purification by column chromato-
graphy on silica gel (gradient elution, 25-100% ethyl acetate in
hexanes). CAlc, CAld, and cinnamic acid were purchased from
Sigma-Aldrich Co. (St Louis, MO). CAlc was purified by column
chromatography on silica gel using 20% ethyl acetate in hexanes as
eluant. Gas chromatography (GC)/MS and LC/MS analyses and
quantification of the diene metabolites were performed as described
previously (Bergstro¨m et al., 2006). LC/MS analysis of CAlc, CAld,
and cinnamic acid was performed using the instrumentation and
method settings described previously (Bergstro¨m et al., 2006) with
the following modifications: mobile phase A consisted of 0.1%
formic acid and 5% acetonitrile in water and mobile phase B of
0.1% formic acid and 5% water in acetonitrile. A linear gradient of
25 to 50% B for 10 minutes followed by 5 minutes of isocratic
elution was used. The mass detector was used in the selected ion
monitoring mode and the following m/z values were monitored; at tR
5–8.6 minutes: 117, 118 (CAlc) and at tR 8.6–9.6 minutes: 131 and
149 (cinnamic acid), 9.6–15:133 (CAld). Quantification of CAld was
carried out using an external standard curve of CAld dissolved in
acetonitrile/water 1:1.
Human genome U133 PLUS 2.0 (Affymetrix)
Experimental procedures for the U133 PLUS 2.0 GeneChips were
performed according to the Affymetrix GeneChip Expression
Analysis Technical Manual. Briefly, double-stranded cDNA was
synthesized from 5mg poly Aþ RNA from 18 healthy human
skin samples (BD Biosciences, Palo Alto, CA), or polyAþ RNA
derived from three human liver samples (BD Biosciences) by
means of the SuperScript Choice system (Gibco BRL, Carlsbad,
CA) and a T7-(dT) 24 primer (MWG Biotech, Ebersberg, Germany).
After second-strand synthesis, biotin-labelled cRNA was generated
by in vitro transcription using the BioArray High Yield RNA
Transcript Labeling Kit (Affymetrix, High Wycombe, UK). The
biotinylated cRNA was cleaned using the RNeasy Mini Kit (Qiagen
GmbH, Hilden, Germany) and then hybridized to an Affymetrix
Human Genome U133 PLUS 2.0 array, which contains more than
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14,500 well-characterized human genes that have been previously
characterized in terms of function or disease association. Fluores-
cence signals of hybridized probes were scanned on a HP
GeneArray scanner (Agilent Technologies, Boeblingen, Germany).
Data analysis was performed by using the Genespring Software
(Agilent Technologies). The software includes algorithms that
determine whether expression of a gene is absent, marginal, or
present.
Quantitative reverse transcriptase-PCR and preparation of the
skin-like rhCYP cocktail
Purified polyAþ RNA from 18 healthy human skin samples (BD
Biosciences) and a polyAþ RNA sample of non-stimulated NHEKs
or polyAþ RNA derived from three human liver samples (BD
Biosciences) were reverse transcribed with the TaqMan Reverse Trans-
cription Reagents kit (Applied Biosystems, Weiterstadt, Germany)
with random hexamers as primers. TaqMan experiments were carried
out on an ABI PRISM 7000 Sequence Detection System (Applied
Biosystems) using Assay-on-Demand Gene Expression Products
(Applied Biosystems) for CYP1A1 (Hs00153120), 1B1 (Hs00164383),
2B6 (Hs00167937), 2D6 (Hs00164385), 2C9 (Hs00426397), 2C19
(Hs00426380), 2E1 (Hs00559368), 3A4 (Hs00430021) as well as 3A5
(Hs00241417) according to the manufacturer’s recommendations. An
Assay-on-Demand product for 18S rRNA (Hs99999901) was used as
an internal reference to normalize the target transcripts. CYP and 18S
rRNA sequences were amplified independently in separate reaction
wells in triplicate. The real-time PCR efficiencies were determined
for each primer/probe set from standard curves generated from serial
dilutions of polyAþ RNA derived from three human liver samples
(BD Biosciences) or untreated NHEKs (Applied Biosystems, User
Bulletin 2). Briefly, a cDNA sample of unstimulated NHEKs or liver
cells was 2-fold serial diluted to construct standard curves for human
CYP1A1, 1B1, 2B6, 2D6, 2C9, 2C19, 2E1, 3A4 as well as 3A5. The
relative differences between the expression of the various CYP
enzymes in skin specimen were calculated using a mathematical
formula, which evens out the differences in PCR efficiencies:
x2
x1
¼ 10ðn2n1Þ=ðs2s1Þ
(s¼ slope; n¼ number of PCR cycles; x¼ amount of CYP (pmol))
This formula was modulated from the standard formula for the
calculation of efficiency of PCR amplification (Livak and Schmittgen,
2001) measuring the number of cycles (n) necessary to amplify the
same amount of product (Y) for each CYP:
Y ¼ xð1 þ EÞn
(Y¼ amount of product, x¼ amount of copies at start of PCR,
E¼ efficiency, n¼ number of PCR cycles)
E ¼ 101=s  1
(E¼ Efficiency, s¼ slope).
Stability experiments
To study the stability of the endocyclic and exocyclic epoxide
formed from the diene under the microsomal incubation conditions,
10 mM solutions of each epoxide in both potassium phosphate
(100 mM, pH 7.4) and HEPES buffer (50 mM, pH 7.4) were prepared.
The epoxide solutions (0.5 ml) were either gently shaken in a
waterbath at 371C and extracted after 30 minutes, or extracted
immediately without prior incubation and analyzed using GC/MS.
To determine the amounts of diols formed from the exocyclic
epoxide, acetonitrile (0.5 ml) was added to the exocyclic epoxide
solution after incubation and the samples were analyzed using
LC/MS. The incubated samples were compared to immediately
extracted samples, except for the exocyclic epoxide, as this epoxide
hydrolyzes rapidly in any water-based media.
Liver microsomal incubations
The microsomal incubations were performed using human liver
microsomes (0.5 mg of protein, pooled from 29 male and female
donors, BD Biosciences) or mouse liver microsomes (0.5 mg of
protein, female CD-1 mouse liver microsomes, BD Biosciences),
substrate (200 mM), potassium phosphate buffer (100 mM, pH 7.4) and
a nicotinamide adenine dinucleotide phosphate (NADPH) regener-
ating system (1.3 mM NADPþ , 3.3 mM glucose-6-phosphate, 0.4 U/ml
glucose-6-phosphate dehydrogenase, and 3.3 mM magnesium chlor-
ide; BD Biosciences) in a total volume of 500 ml. All incubations
were performed in duplicate and control samples were run in the
absence of substrate or in the absence of the NADPH regenerating
system. The incubations were initialized by addition of the NADPH
regenerating system after 3 minutes of pre-incubation at 371C and
terminated after 15, 30, or 60 minutes. Analysis was performed using
GC/MS and LC/MS.
Keratinocyte incubations
NHEKs were obtained from foreskin specimen by dispase separation
(BD Biosciences) of the epidermal sheet from the dermis and
subsequent trypsin digestion (Cambrex, Walkersville, MD) of the
epidermis (Baron et al., 2005). Trypsin was neutralized with Trypsin
Neutralization Solution (Cambrex). Cells were fed with Keratinocyte
Growth Medium (KGM bullet kit C3111, Cambrex) three times a
week. For this study, proliferating keratinocytes in the first and
second passage were used. The diene was added to NEHKs in
culture to a final concentration of 200 mM. The supernatant was
collected after 8 or 24 hours incubation at 371C and 5% CO2. After
trypsin digestion, the cells were added to acetonitrile/water (1:1),
sonicated and centrifuged (3,000 r.p.m. for 5 minutes at 41C). The
supernatants were concentrated to dryness with a stream of nitrogen,
and then acetonitrile (50 ml) was added. The solutions were analyzed
for major diol of the exocyclic epoxide content using LC/MS.
Incubation with rhCYP cocktails
The liver-like and skin-like cocktails were prepared by mixing
recombinantly expressed CYP bactosomes (coexpressed with CYP-
reductase in E. coli, total rhCYP contents: liver system 104 pmol, skin
system 22.2 pmol; tebu-bio, Offenbach, Germany) according to
Table 1. All incubations contained substrate (200 mM), HEPES buffer
(50 mM, pH 7.4), MgCl2 (30 mM) and NADPH (1 mM) in a total
volume of 500ml. The incubations were performed in duplicate
and were initialized by addition of NADPH after 3 minutes of
pre-incubation at 371C and terminated after 15, 30, or 60 minutes.
Control samples were run in the absence of substrate, in the absence
of NADPH or using heat-deactivated enzymes. Analysis was
performed using GC/MS and LC/MS. Incubations of CAlc (200 mM)
with the skin-like rhCYP cocktail were performed and analyzed as
described above.
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Incubation with single rhCYP enzymes
The incubations were performed using individual recombinantly
expressed human CYP bactosomes (20 pmol; CYP1A1, 3A5, 1B1,
2B6, 2E1, 1A2, 3A4, 2C9, 2C19, or 2D6, all coexpressed with CYP-
reductase in E. coli, tebu-bio). The incubations were otherwise
performed as described for the incubations containing rhCYP
cocktails.
Determination of sensitizing capacity in the LLNA
The LLNA (Kimber et al., 1995) was used to determine the sensitizing
capacity of the major diol formed from the exocyclic epoxide and
was performed as described previously (Nilsson et al., 2005). The
diol was tested in five different concentrations (1, 5, 10, 15, and 22%
w/v corresponding to 0.055, 0.27, 0.55, 0.82, and 1.2 M) using mice
in groups of three. The vehicle used was acetone/olive oil (4:1).
Owing to poor solubility of the test compound in the vehicle, 22%
was the highest test concentration possible. Results are expressed as
mean d.p.m./lymph node for each experimental group and as
stimulation index, that is test group/control group ratio. Test
materials that give rise to a stimulation index greater than three are
considered to be positive in the LLNA and for these compounds EC3-
values (the estimated concentration required to induce an stimula-
tion index of three) can be calculated by linear interpolation
(Basketter et al., 1999). Classification of sensitizing potency was
performed according to the following: (%)o0.1 extreme,X0.1–o1
strong, X1–o10 moderate, X10–o100 weak (ECETOC, 2003).
Dendritic cell assay
Human peripheral blood monocytes were separated from purchased
single donor buffy coats (Institut fu¨r Transfusionsmedizin, Universi-
ta¨tsklinikum Aachen, Germany) over a Ficoll-Paque gradient
(Amersham Pharmacia Biotech, Uppsala, Sweden) and CD2, CD7,
CD19, CD56, CD16, and CD235a positive leukocytes were depleted
using a negative monocyte isolation kit (Dynals Monocyte
Negative Isolation Kit, Invitrogen, Oslo, Norway). The remaining
monocytes were suspended in complete medium consisting of
Roswell Park Memorial Institute-1640 (PAA laboratories, Pasching,
Germany) enriched with 1.5% heat-inactivated autologous plasma
and 1.1 ml L-glutamine/100 ml. The cell suspension was plated at
a density of 3 106 cells/reaction well. In order to induce DC
differentiation, the culture medium was supplemented with 800 U/
ml GM-CSF and 1,000 U/ml IL-4 (R&D-System, Bu¨hlmann, Basel,
Switzerland) and the cells were kept at 371C and 5% CO2 for 3 days.
On day 4, 1,600 U/ml GM-CSF and 1,000 U/ml IL-4 were added.
The test compounds were individually prepared in complete
medium: 2,4,6-trinitrobenzene sulfonic acid (200 mg/ml), SDS
(5mg/ml), DMSO (0.1%), diene (100 mM), exocyclic epoxide
(200mM), endocyclic epoxide (200 mM), and the major diol of the
exocyclic epoxide (200 mM). Analysis of DC activation by the diene
at a lower concentration (100 mM) compared to the epoxides and the
diol, was performed, as prior toxicity testing revealed that higher
concentrations (200 mM) were, in some experiments, not tolerated by
the immature DCs (data not shown). Each test solution was
incubated with at least 6 106 DCs for 30 hours. RNA isolation
(RNA Isolation Kit, Roche, Penzberg, Germany) of the treated cells
was performed on day 5. The RNA-samples were harvested and
stored at 801C Before quantitative reverse transcriptase-PCR
analysis. PCR analysis was performed as described above for the
CYP expression analysis, using an Assay-on-Demand primer/probe
set (Applied Biosystems), which is specific for the detection of IL-8
mRNA expression (Hs00174103). An Assay-on-Demand product for
18S rRNA (Hs99999901) was used as an internal reference.
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SUPPLEMENTARY MATERIAL
Table S1. Expression of CYP enzymes in human skin and liver specimen
detected by Affymetrix U133 PLUS 2.0 Gene Chips and analyzed by
Genespring Software.
Table S2. Local lymph node assay (LLNA)a responses for the major diol
formed from the exocyclic epoxide.
Figure S1. Dose–response curve for the major diol formed from the exocyclic
epoxide tested in the local lymph node assay (LLNA).
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